Clinical Trials Browser

Carcinoma, Hepatocellular, Liver Neoplasms, Neoplasms

Uterine Cervical Neoplasms

Triple Negative Breast Neoplasms

Carcinoma, Non-Small-Cell Lung

Neoplasms, Unknown Primary

Squamous Cell Carcinoma of Head and Neck

Small Cell Lung Carcinoma

SCLC, Extensive Stage

Carcinoma, Non-Small-Cell Lung

Anus Neoplasms

Adenocarcinoma, Paraganglioma, Pheochromocytoma, Neuroendocrine Tumors, Thyroid Carcinoma, Anaplastic

Locally Advanced Cervical Cancer

Carcinoma, Non-Small-Cell Lung

Adenocarcinoma, Mucinous, Neoplasm Metastasis, Neoplasms

Recurrent Bladder Urothelial Carcinoma

Carcinoma, Hepatocellular

Carcinoma, Transitional Cell, Neoplasm Metastasis, Neoplasms

Urinary Bladder Neoplasms, Carcinoma, Transitional Cell

Small Cell Lung Cancer Extensive Stage

Neoplasm Metastasis

Carcinoma, Squamous Cell, Esophageal Neoplasms, Neoplasm Metastasis

Anal Canal Carcinoma, Squamous Cell Carcinoma of Head and Neck, Uterine Cervical Neoplasms

Breast Neoplasms, Neoplasms, Triple Negative Breast Neoplasms

Carcinoma, Non-Small-Cell Lung

Carcinoma, Non-Small-Cell Lung

Colorectal Neoplasms

Small Cell Lung Carcinoma

Urinary Bladder Neoplasms, Carcinoma, Transitional Cell, Ureteral Neoplasms, Urethral Neoplasms

Biliary Tract Neoplasms, Urinary Bladder Neoplasms, Neoplasms

Small Cell Lung Carcinoma

Biliary Tract Neoplasms

Mesothelioma, Malignant, Carcinoma, Non-Small-Cell Lung

Breast Neoplasms

Breast Neoplasms, Triple Negative Breast Neoplasms

Carcinoma, Transitional Cell

Carcinoma, Non-Small-Cell Lung

Squamous Cell Carcinoma of Head and Neck

Gallbladder Neoplasms, Cholangiocarcinoma

Urinary Bladder Neoplasms

Urinary Bladder Neoplasms

Carcinoma, Non-Small-Cell Lung

Colonic Neoplasms, Neoplasm Metastasis, Rectal Neoplasms, Colorectal Neoplasms

Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Carcinoma, Transitional Cell, Head and Neck Neoplasms, Melanoma

Advanced Non-small Cell Lung Cancer

Carcinoma, Non-Small-Cell Lung

Carcinoma, Non-Small-Cell Lung

Clinical Trials

Trial of Atezolizumab and Bevacizumab With SRF388 or Placebo in Patients With Hepatocellular Carcinoma

SKYSCRAPER-04

Nab-Paclitaxel and Atezolizumab Before Surgery in Treating Patients With Triple Negative Breast Cancer

A Study of Tiragolumab in Combination With Atezolizumab in Chemotherapy-Naïve Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer

CUPISCO

SKYSCRAPER-09

Carboplatin, Etoposide, and Atezolizumab With or Without Trilaciclib (G1T28), a CDK4/6 Inhibitor, in Extensive-Stage SCLC

SPACE

Atezolizumab and Tiragolumab in Patients With NSCLC or Advanced Solid Tumors Having Had Prior Treatment With a PD-1 Inhibitor

SCARCE

CABATEN

ATEZOLACC

GFPC 06-2018

Cobimetinib and Atezolizumab in Treating Participants With Advanced or Refractory Rare Tumors

Atezolizumab in Treating Patients With Recurrent BCG-Unresponsive Non-muscle Invasive Bladder Cancer

FMT in IT-refractory HCC - FAB-HCC Pilot Study

AUREA

ImmunoCobiVem

ABACUS

TREASURE

CRAFT: The NCT-PMO-1602 Phase II Trial

Second-line Cabozantinib and Atezolizumab in Patients With Recurrent or Metastatic Esophageal Squamous Cell Carcinoma

VolATIL

Atezolizumab in Combination With Bevacizumab in Patients With Unresectable Locally Advanced or Metastatic Mucosal Melanoma

ALICE

ATEZO-BRAIN

A Study of Atezolizumab as Neoadjuvant and Adjuvant Therapy in Resectable Non-Small Cell Lung Cancer (NSCLC) - Lung Cancer Mutation Consortium (LCMC3)

Capecitabine and Bevacizumab With or Without Atezolizumab in Treating Patients With Refractory Metastatic Colorectal Cancer

Match

Atezolizumab and CYT107 in Treating Participants With Locally Advanced, Inoperable, or Metastatic Urothelial Carcinoma

My Pathway: A Study Evaluating Herceptin/Perjeta, Tarceva, Zelboraf/Cotellic, Erivedge, Alecensa, and Tecentriq Treatment Targeted Against Certain Molecular Alterations in Participants With Advanced Solid Tumors

CeLEBrATE

A Study of Atezolizumab With or Without Bevacizumab in Combination With Cisplatin Plus Gemcitabine in Patients With Untreated, Advanced Biliary Tract Cancer

SAKK 17/18 (ORIGIN) MPM & NSCLC >1st Line Gemci & Atezo Ph II

ECLIPSE

A Study to Investigate the Efficacy and Safety of Atezolizumab (Tecentriq) in Previously-Treated Patients With Advanced Thymic Carcinoma

ATRACTIB

Neoadjuvant Atezolizumab in Localized Bladder Cancer

A Study of Atezolizumab in Combination With Bevacizumab in Patients With EGFR Mutation Positive Stage IIIB-IV Non-Squamous Non-Small Cell Lung Cancer

PIONEER

A Study Evaluating the Safety and Efficacy of Cobimetinib Plus Atezolizumab in BRAFV600 Wild-type Melanoma With Central Nervous System Metastases and Cobimetinib Plus Atezolizumab and Vemurafenib in BRAFV600 Mutation-positive Melanoma With Central Nervous System Metastases

Atezolizumab With or Without Cobimetinib in Treating Patients With Metastatic Bile Duct Cancer That Cannot Be Removed by Surgery or Gallbladder Cancer

A Study of Atezolizumab in Participants With Locally Advanced or Metastatic Urothelial Bladder Cancer (Cohort 2)

A Study of Atezolizumab in Participants With Locally Advanced or Metastatic Urothelial Bladder Cancer (Cohort 1)

CHANCE

CLIMB

CHEERS

Evaluating the Efficacy of Atezolizumab in Advanced Non-small Cell Lung Cancer (NSCLC)

Neoadjuvant MPDL3280A, Nab-paclitaxel and Carboplatin (MAC) in NSCLC

PRINCEPS